Colorectal Cancer
CRC screening response suggests a ‘greater opportunity to leverage’ FIT in younger adults
CHICAGO — Individuals aged 45 to 49 years who were mailed fecal immunochemical tests for colorectal cancer screening completed the tests in a timelier manner than those aged 50 years and older, according to data from Digestive Disease Week.
Elevated BMI in adulthood may increase GI cancer risk, regardless of aspirin use
Overweight and obese BMI during adulthood appeared associated with increased risk for colorectal cancer and noncolorectal gastrointestinal cancers, according to study results published in JAMA Network Open.
Aspirin, NSAIDs use may reduce risk for early-onset CRC, further study warranted
CHICAGO — The regular use of aspirin and NSAIDs was associated with a lower risk for early-onset adenomas, especially those with advanced histology, according to a researcher at Digestive Disease Week.
Dedicated patient navigator cost-effective, improved FIT return rates by nearly 38%
CHICAGO — Adding a dedicated patient navigator improved fecal immunochemical testing completion and return rates and resulted in significant savings to the health care system, according to data presented at Digestive Disease Week.
Nonwhite patients in rural areas ‘even less likely’ to undergo colorectal cancer screening
CHICAGO — Race, ethnicity and rurality have a significant impact on colorectal cancer screening disparities, highlighting the need for interventions to overcome these barriers, according to data presented at Digestive Disease Week.
Combination of patient, provider outreach boosts CRC screening in high-risk individuals
CHICAGO — A multicomponent strategy, which included patient and provider outreach, increased colorectal cancer screening in individuals overdue for colonoscopy who have a family history of CRC, according to data at Digestive Disease Week.
1 in 6 early-onset colorectal cancer survivors diagnosed with subsequent cancer
CHICAGO — Among those who survived early-onset colorectal cancer, approximately 16% developed a second cancer, with higher risk reported among men, according to a population-based study presented at Digestive Disease Week.
At Moonshot forum, expert in early-onset colorectal cancer calls for greater trial funding
Cathy Eng, MD, FACP, FASCO, joined a panel of experts at the White House Cancer Moonshot Colorectal Cancer Forum in highlighting the need for greater patient participation in and funding for cancer clinical trials.
‘One day at a time’: Star saxophonist cautions Black community on colorectal cancer risks
When James Casey, acclaimed saxophonist for the Trey Anastasio Band, first began feeling the dull ache on the right side of his abdomen, it was easy enough to ignore — and colorectal cancer was the last thing he would have considered.
Adding panitumumab vs. bevacizumab to chemotherapy extends OS in colorectal cancer subset
The addition of panitumumab vs. bevacizumab to standard first-line chemotherapy significantly extended OS for certain patients with RAS wild-type metastatic colorectal cancer, according to data published in JAMA.